James Hardie Sells European Business to Holcim for €840M, Authorizes $250M Buyback
JHX sits 84% above its 52-week low of $16.46.
Summary
James Hardie agreed to sell its European fibre gypsum and cement-bonded business to Holcim for €840 million and authorized a $250 million buyback. The company will also close its European fiber cement operations.
Key Events · M&A and Partnerships · JHX
-
European Business Sold to Holcim
James Hardie agreed to sell its European fibre gypsum and cement-bonded products business to Holcim for €840 million (~$980 million USD) in cash, subject to customary adjustments.
-
Proceeds to Reduce Debt
Approximately $600 million of the proceeds will be used to repay debt, accelerating progress toward the company's target of net leverage below 2.0x by September 30, 2027.
-
$250M Share Repurchase Authorized
The Board authorized a new $250 million share repurchase program, which may be executed through open-market purchases, accelerated share repurchases, or other methods.
-
European Fiber Cement Closure
James Hardie intends to close its European fiber cement business, subject to legal, regulatory, and employee consultation requirements, with associated restructuring costs.
Analysis · JHX · Manufacturing
James Hardie is exiting its European fibre gypsum and cement-bonded products business, selling it to Holcim for €840 million (~$980 million USD). The deal is expected to close in the first half of 2027 and will sharpen the company's focus on North America and other core growth regions. Proceeds will be used to pay down debt and fund a new $250 million share repurchase program. The company also intends to wind down its European fiber cement operations, which will incur restructuring costs but remove a drag on margins. This is a significant portfolio reshaping that should improve profitability and return on invested capital, though the fiber cement closure carries execution risk.
At the time of this filing, JHX was trading at $30.34 on NYSE in the Manufacturing sector, with a market capitalization of approximately $17.4B. The 52-week trading range was $16.46 to $31.36. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.